Use este identificador para citar ou linkar para este item: http://repositorio.ufc.br/handle/riufc/62942
Tipo: Artigo de Periódico
Título: SARS‑COV‑2 infection outcomes in patients with congenital generalized lipodystrophy
Autor(es): Madeira, Mayara Ponte
Freire, Erika Bastos Lima
Fernandes, Virginia Oliveira
Lima, Grayce Ellen da Cruz Paiva
Melo, Ivana da Ponte
Montenegro, Ana Paula Dias Rangel
Freire, José Ednésio da Cruz
Moreira‑Nunes, Caroline de Fátima Aquino
Montenegro, Raquel Carvalho
Colares, Jeová Keny Baima
Montenegro Junior, Renan Magalhães
Palavras-chave: Covid-19;Lipodistrofia;Lipodystrophy;Lipodistrofia Generalizada Congênita;Lipodystrophy, Congenital Generalized;Diabetes Mellitus;Resistência à Insulina;Insulin Resistance
Data do documento: 2021
Instituição/Editor/Publicador: Diabetology & Metabolic Syndrome
Citação: MADEIRA, Mayara Ponte et al. SARS‑COV‑2 infection outcomes in patients with congenital generalized lipodystrophy. Diabetol Metab Syndr, v. 13, n. 65, p. 1-9, jun. 2021. Disponível em: http://www.repositorio.ufc.br/handle/riufc/62942. Acesso em: 13/12/2021.
Abstract: Background: A new strain of human coronavirus (HCoV) spread rapidly around the world. Diabetes and obesity are associated with a worse prognosis in these patients. Congenital Generalized Lipodystrophy (CGL) patients generally have poorly controlled diabetes and require extremely high doses of insulin. There is no documentation in the literature of cases of COVID in CGL patients. Thus, we aimed to evaluate the prevalence of SARS-CoV-2 infection in CGL patients, and the association of their clinical and metabolic characteristics and outcomes. Methods: This is a cross-sectional study carried out between July and October 2020. Clinical data collected were respiratory or other flu-like symptoms, need of hospitalization in the last three months, CGL comorbidities, and medications in use. Cholesterol, triglycerides, glycohemoglobin A1c levels, anti-SARS-CoV-2 antibodies and nasopharyngeal swab for RT-qPCR were also obtained in all CGL patients. Mann-Whitney U test was used to analyze the characteristics of the participants, verifying the non-adherence of the data to the Gaussian distribution. In investigating the association between categorical variables, we used Pearson’s chi-square test and Fisher’s exact test. A significance level of 5% was adopted. Results: Twenty-two CGL patients were assessed. Eight subjects (36.4%) had reactive anti-SARS-CoV-2 antibodies. Only one of these, also presented detectable RT-qPCR. Five individuals (62.5%) were women, median age of 13.5 years (1 to 37). Symptoms like fever, malaise, nausea, diarrhea and chest pain were present, and all asymptomatic patients were children. All subjects had inadequate metabolic control, with no difference between groups. Among positive individuals there was no difference between those with AGPAT2 (75%) and BSCL2 gene mutations (25%) (p > 0.05). No patient needed hospitalization or died. Conclusions: We described a high prevalence of SARS-CoV-2 infection in CGL patients with a good outcome in all of them. These findings suggest that at least young CGL patients infected by SARS-COV-2 are not at higher risk of poor outcome, despite known severe metabolic comorbidities.
URI: http://www.repositorio.ufc.br/handle/riufc/62942
ISSN: 1758-5996
Aparece nas coleções:COVID-19 - Trabalhos relacionados
PPGF - Artigos publicados em revistas científica

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
2021_art_mpmadeira.pdf819,62 kBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.